|Articles|April 1, 2013
- Pharmaceutical Executive-04-01-2013
- Volume 0
- Issue 0
PE, April 2013 Cover Image
S
Advertisement
Cover
Articles in this issue
about 13 years ago
Country Report: Belgiumabout 13 years ago
On-Market Pricing Strategiesabout 13 years ago
Is National Drug Pricing Freedom in Europe Nearing its Expiry Date?about 13 years ago
Evidence-Based Marketing: From Rise to Stall—and Ultimate Triumphabout 13 years ago
Pfizer's Quality by Design Approach to Trial Managementabout 13 years ago
Woman of the Year 2013about 13 years ago
Key to Brand Positioning: Look Inside Your Heartabout 13 years ago
Full Disclosure for PharmaAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pharma M&A Roundup: Ipsen to Acquire Kartos Therapeutics, Zymeworks to Acquire Theravance Biopharma
2
Why ‘Fully Staffed’ Field Teams Still Miss Revenue Targets—and How Pharma Can Fix It
3
U.S. House Committee Investigating Drugmakers Involved in China Drug Trials: Report
4
Pharmaceutical Executive Daily: Ipsen Enters Merger Agreement to Acquire Kartos Therapeutics
5